Clinical Trials and Research Staff at Florida Cancer Specialists & Research Institute
Advanced, New Therapies and Technology
Early and late-phase studies conducted with participation from our three Drug Development Units and clinics across our practice continue to reveal new discoveries in the use of targeted immunotherapies, radiopharmaceuticals, precision medicine and molecular-based treatments that effectively kill, block or inhibit the growth of cancer cells. The impact of our work is advancing the course of care for cancer patients on a global scale.
Tadeu Ambros, MD
Lalit Aneja, MD
Liliana Bustamante, MD
Raymond Esper, MD, PhD
Faithlore Gardner, MD
Alexander Glick, MD
Kristen Gonter-Aubin, DO
Elizabeth Guancial, MD
Amir Harandi, MD, MS
Blessy Jacob, MD
Fadi Kayali, MD
Christopher Lobo, MD
Anjan J. Patel, MD
Ivor Percent, MD
Andres O. Soriano, MD
Pavan Kumar Tandra, MD
Syed F. Zafar, MD
Susmitha Apuri, MD
Viralkumar Bhanderi, MD
Jennifer L. Cultrera, MD
Tien Do, MD
Adewale Fawole, MD
Maria Regina Flores, MD
Gustavo A. Fonseca, MD, FACP
Sunil Gandhi, MD, FACP
Lucio N. Gordan, MD
Maen Hussein, MD
Muhammad Imam, MD
Joseph R. Mace, MD
Paresh Patel, MD
Vipul Patel, MD
Jessica Stine, MD
R. Waide Weaver, MD
David D. Wright, MD
Disease Site Committee
Our Disease Site Committee is comprised of FCS medical oncologist and hematologist researchers who meticulously address the unique challenges and intricacies associated with site-specific types of cancer. By concentrating their expertise and resources, these teams are poised to drive groundbreaking advancements in the understanding, diagnosis, and treatment of cancer.
